Skip to content
← Back to this collection

PUBLICATIONS · 38033284

Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2024 Mar 1
First author
Brivio E

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Brivio E
      type
      Author
    2. name
      Pennesi E
      type
      Author
    3. name
      Willemse ME
      type
      Author
    4. name
      Huitema ADR
      type
      Author
    5. name
      Jiang Y
      type
      Author
    6. name
      van Tinteren HDR
      type
      Author
    7. name
      van der Velden VHJ
      type
      Author
    8. name
      Beverloo BH
      type
      Author
    9. name
      den Boer ML
      type
      Author
    10. name
      Rammeloo LAJ
      type
      Author
    11. name
      Hudson C
      type
      Author
    12. name
      Heerema N
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Brivio E
      type
      Author
    2. name
      Pennesi E
      type
      Author
    3. name
      Willemse ME
      type
      Author
    4. name
      Huitema ADR
      type
      Author
    5. name
      Jiang Y
      type
      Author
    6. name
      van Tinteren HDR
      type
      Author
    7. name
      van der Velden VHJ
      type
      Author
    8. name
      Beverloo BH
      type
      Author
    9. name
      den Boer ML
      type
      Author
    10. name
      Rammeloo LAJ
      type
      Author
    11. name
      Hudson C
      type
      Author
    12. name
      Heerema N
      type
      Author
    bibliography ids
    1. nci-bib-0bed21a62f2812a39d917435
    book metadata
    content sha256
    190750472dad6634763847d78266a44f187b258092fade7cf94a802f60a42f5b
    document type
    citation
    dois
    1. 10.1200/JCO.23.00897
    electronic publication date
    display
    2023 Nov 30
    precision
    day
    year
    2023
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:38033284
    immutable id
    pubmed:38033284@190750472dad6634763847d78266a44f187b258092fade7cf94a802f60a42f5b
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    7
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    821-831
    volume
    42
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      38033284
      provenance
      batch id
      6d213eecf21b6b7867cb
      provider
      NCBI PubMed ESummary
      record sha256
      544d4fdb826d380164bae4ee3c9e620af27473c91d8cc6d19af2fa9f387bed21
      response sha256
      684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
      retrieved at
      2026-09-09T23:48:19.049083+00:00
      publication date
      display
      2024 Mar 1
      precision
      day
      year
      2024
      publication types
      1. Clinical Trial, Phase I
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/38033284/
      title
      Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.

      Preserved source evidence · Not medical advice